Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 169

Results For "PLI"

2955 News Found

Cipla’s Indore plant joins the WEF's Lighthouse Network
Digitisation | October 12, 2022

Cipla’s Indore plant joins the WEF's Lighthouse Network

Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations


WEF recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network
Digitisation | October 12, 2022

WEF recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network

Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum


Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine
Biotech | October 11, 2022

Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine

UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027


Healthium launches Theruptor Novo for diabetic foot ulcers
Healthcare | October 11, 2022

Healthium launches Theruptor Novo for diabetic foot ulcers

Theruptor Novo is a best in class patented product which provides an optimum healing environment and addresses the concerns of chronic wound dressing


Ashland announces Klucel xtend HPC matrix former for extended-release tablets
News | October 11, 2022

Ashland announces Klucel xtend HPC matrix former for extended-release tablets

The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.


Merck announces positive top-line results from Phase 3 Stellar Trail evaluating Sotatercept for the treatment of PAH
Diagnostic Center | October 11, 2022

Merck announces positive top-line results from Phase 3 Stellar Trail evaluating Sotatercept for the treatment of PAH

Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy


Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility
Medical Device | October 09, 2022

Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility

The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries


Thermo Fisher Scientific emphasizes on the need for more disruptive technologies
Medical Device | October 09, 2022

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.


Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets
Drug Approval | October 07, 2022

Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets

Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.


Atul Healthcare to acquire stake in VIMS
News | October 05, 2022

Atul Healthcare to acquire stake in VIMS

The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital